Retina Service, Massachusetts Eye and Ear, Department of Ophthalmology, Harvard Medical School, Boston, Massachusetts.
Department of Ophthalmology, Faculty of Medicine, University of Coimbra, Coimbra, Portugal.
Retina. 2018 Jun;38(6):1145-1155. doi: 10.1097/IAE.0000000000001659.
To determine the association between dark adaption (DA) and different health conditions linked with age-related macular degeneration (AMD).
Cross-sectional study, including patients with AMD and a control group. Age-related macular degeneration was graded according to the Age-Related Eye Disease Study (AREDS) classification. We obtained data on medical history, medications, and lifestyle. Dark adaption was assessed with the extended protocol (20 minutes) of AdaptDx (MacuLogix). For analyses, the right eye or the eye with more advanced AMD was selected. Multivariate linear and logistic regressions were performed, accounting for age and AMD stage.
Seventy-eight subjects (75.6% AMD; 24.4% controls) were included. Multivariate assessments revealed that body mass index (BMI; β = 0.30, P = 0.045), taking AREDS vitamins (β = 5.51, P < 0.001), and family history of AMD (β = 2.68, P = 0.039) were significantly associated with worse rod intercept times. Abnormal DA (rod intercept time ≥ 6.5 minutes) was significantly associated with family history of AMD (β = 1.84, P = 0.006), taking AREDS supplements (β = 1.67, P = 0.021) and alcohol intake (β = 0.07, P = 0.017).
Besides age and AMD stage, a higher body mass index, higher alcohol intake, and a family history of AMD seem to impair DA. In this cohort, the use of AREDS vitamins was also statistically linked with impaired DA, most likely because of an increased severity of disease in subjects taking them.
确定暗适应(DA)与与年龄相关性黄斑变性(AMD)相关的不同健康状况之间的关联。
横断面研究,包括 AMD 患者和对照组。根据年龄相关性眼病研究(AREDS)分类对年龄相关性黄斑变性进行分级。我们获取了病史、药物和生活方式的数据。暗适应使用 AdaptDx(MacuLogix)的扩展方案(20 分钟)进行评估。对于分析,选择右眼或 AMD 更严重的眼睛。进行了多变量线性和逻辑回归,考虑了年龄和 AMD 分期。
共纳入 78 名受试者(75.6%为 AMD;24.4%为对照组)。多变量评估显示,体重指数(BMI;β=0.30,P=0.045)、服用 AREDS 维生素(β=5.51,P<0.001)和 AMD 家族史(β=2.68,P=0.039)与较差的视杆截距时间显著相关。异常的暗适应(视杆截距时间≥6.5 分钟)与 AMD 家族史显著相关(β=1.84,P=0.006),服用 AREDS 补充剂(β=1.67,P=0.021)和饮酒(β=0.07,P=0.017)。
除年龄和 AMD 分期外,较高的体重指数、较高的饮酒量和 AMD 家族史似乎会损害 DA。在本队列中,AREDS 维生素的使用也与 DA 受损具有统计学关联,这很可能是因为服用者疾病的严重程度增加。